Lara Longpre
Chief Development Officer at Mirum Pharmaceuticals, Inc. (MIRM)
Lara Longpre has filed 15 insider reports with the SEC since March 2021, as chief Development Officer at Mirum Pharmaceuticals, Inc. (MIRM). Lara Longpre made no open-market purchases or sales in the last 12 months. In the latest filing, on March 18, 2024, Lara Longpre bought 965 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $10.3K at an average of $10.64 and sold 1,003 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $20.7K at an average of $20.62.
- Filings
- 15
- Companies
- 1
- Bought on market
- $10.3K
- Sold on market
- $116K
Companies where Lara Longpre is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Development Officer | 104,369 | $10.3K | $116K | $10.64 | $96.13+803% | Mar 18, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 9, 2023+$10.3KMIRMLongpre Lara bought $10,268 worth of shares (965 units at $10.64) and sold $20,684 worth of shares (1,003 units at $20.62), decreasing direct ownership by 0.04% to 104,369 unitsForm 4Open-market purchaseOpen-market sale
- Feb 2, 2024-$22.2KMIRMLongpre Lara sold $22,184 worth of shares (847 units at $26.19), decreasing direct ownership by 0.80% to 104,407 unitsForm 4Open-market sale
- Jan 23, 2024MIRMSEC Form 4 filed by Longpre LaraForm 4Grant or award
- Jan 8, 2024-$28.6KMIRMLongpre Lara sold $28,568 worth of shares (1,019 units at $28.04), decreasing direct ownership by 0.96% to 105,254 unitsForm 4Open-market sale
- Nov 10, 2023MIRMLongpre Lara was granted 434 shares, increasing direct ownership by 0.41% to 106,273 unitsForm 4Grant or award
- Jul 3, 2023-$25.7KMIRMSEC Form 4 filed by Longpre LaraForm 4Open-market sale
- May 10, 2023MIRMSEC Form 4 filed by Longpre LaraForm 4Grant or award
- Jan 31, 2023MIRMSEC Form 4: Longpre Lara was granted 9,625 shares, increasing direct ownership by 10% to 106,159 unitsForm 4Grant or award
- Nov 10, 2022MIRMSEC Form 4: Longpre Lara was granted 82 shares, increasing direct ownership by 0.09% to 96,534 unitsForm 4Grant or award
- May 10, 2022MIRMSEC Form 4: Longpre Lara was granted 1,454 shares, increasing direct ownership by 2% to 96,452 unitsForm 4Grant or award
- Jan 6, 2022MIRMSEC Form 4: Longpre Lara was granted 10,000 shares, increasing direct ownership by 12% to 94,998 unitsForm 4Grant or award
- Nov 10, 2021MIRMSEC Form 4: Longpre Lara was granted 753 shares, increasing direct ownership by 0.89% to 84,998 unitsForm 4Grant or award
- Oct 1, 2021-$18.5KMIRMSEC Form 4: Longpre Lara was granted 8,125 shares and sold $18,505 worth of shares (961 units at $19.26), increasing direct ownership by 9% to 84,245 units (tax liability)Form 4Grant or awardOpen-market sale
- May 10, 2021MIRMSEC Form 4: Longpre Lara was granted 1,259 units of Common Stock, increasing direct ownership by 2% to 77,081 unitsForm 4Grant or award
- Jan 7, 2021MIRMSEC Form 4 filed by Lara LongpreForm 4Grant or award
Compare Lara Longpre with
- Lara Longpre vs Christopher Peetz1 shared
- Lara Longpre vs Saira Ramasastry1 shared
- Lara Longpre vs Laura Brege1 shared
- Lara Longpre vs Joanne Quan1 shared
- Lara Longpre vs Eric Bjerkholt1 shared
- Lara Longpre vs Jolanda Howe1 shared
Other insiders at the same companies
- Christopher PeetzMIRM
- Saira RamasastryMIRM
- Laura BregeMIRM
- Joanne QuanMIRM
- Robert Paul MyersMIRM
- Eric BjerkholtMIRM
- Jolanda HoweMIRM
- Timothy P WalbertMIRM
- Lon CardonMIRM
- William FaireyMIRM
- Patrick J HeronMIRM
- Laurent FischerMIRM
- Michael G GreyMIRM
- Peter RadovichMIRM
Questions about Lara Longpre
- What is Lara Longpre's role at Mirum Pharmaceuticals, Inc.?
- Lara Longpre reports to the SEC as chief Development Officer at Mirum Pharmaceuticals, Inc. (MIRM), according to the latest filing on March 18, 2024.
- How many shares does Lara Longpre own?
- After the latest filing that states it, Lara Longpre directly owned 104,369 shares of Mirum Pharmaceuticals, Inc. (MIRM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Lara Longpre bought or sold stock recently?
- The most recent open-market purchase was on January 9, 2023: bought 965 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $10.3K at an average of $10.64. The most recent open-market sale was on January 9, 2023: sold 1,003 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $20.7K at an average of $20.62.
- How do I get alerts when Lara Longpre files?
- Follow Lara Longpre on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Lara Longpre (SEC CIK 0001780347). Totals count each trade once, skipping amendments whose original is on file, from Mar 9, 2021 on. View on SEC EDGAR · Get this as JSON